Actively Recruiting
Decoding Death and Dying in People With Dementia by Digital Thanotyping
Led by University of Bergen · Updated on 2024-05-31
480
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
U
University of Bergen
Lead Sponsor
L
Leiden University
Collaborating Sponsor
AI-Summary
What this Trial Is About
How can healthcare professionals recognize that a person with dementia is at the end of life? When people are dying, their physical, mental, and social abilities are gradually declining. No reliable method of predicting perceived dying currently exists although the technology is available (sensors, algorithms). The aim of Decoding Death and Dying in Dementia by Digital thanotyping (5-D) is to provide methods and tools to diagnose and describe dying to an unprecedented level of accuracy and robustness, within a timespan larger than is possible now, focusing on the case of dying people with dementia as one of the most vulnerable and difficult to study groups. 5-D combines clinical assessment tools with wearable sensing technology to monitor a) pain and distressing symptoms, b) behavioral and psychological symptoms in dementia (BPSD), c) oral changes, and to decode "the point of no return" as the beginning of perceived dying. To obtain this outcome in nursing home patients with dementia, the investigator will test the main hypothesis: from monitoring the evolution of thanotype components over time and their interdependencies, the prediction of the "point of no return" is possible. The objectives of 5-D are: O1. Collect data using sensors and validated assessment scales. O2. Develop estimation methods for BPSD from sensor measurements. O3. Develop digital tools to capture the expression of pain. O4. Determine the relationship between breathing and oral symptoms. O5. Develop models for symptom interdependencies at the end of life and the "point of no return". O6. Perform human-in-the-loop validation of developed tools, models, and algorithms. The ground-breaking interdisciplinary novelty of 5-D endeavors to enhance the understanding of end-of-life underlying pain and symptoms in people with dementia. Advancing our theoretical knowledge to uncover how, when, and why perceived dying can be identified opens the doors for transferable research across several scientific fields
CONDITIONS
Official Title
Decoding Death and Dying in People With Dementia by Digital Thanotyping
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Nursing home resident
- Age over 64 years
- People with dementia or likely diagnosis of dementia
- Score less than 4 on the 4 A's Test for Delirium (no delirium)
You will not qualify if you...
- People without dementia or cognitive impairment
- People considered in health status emergency with less than 6 weeks to live
- People not living in a nursing home
- People without informed or presumed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bergen Røde Kors Sykehjem AS
Bergen, Vestland, Norway, 5043
Actively Recruiting
Research Team
B
Bettina S. Husebø, PhD
CONTACT
M
Monica Patrascu, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here